TLV's web application for TNF inhibitors shows room for savings

15 October 2021 - The TLV, has developed a web application that will show the regions' use of TNF inhibitors ...

Read more →

European authorities launch HTA network

12 October 2021 - On 29 September, the heads of 19 European HTA authorities met to launch a network for strategic ...

Read more →

Health economic assessment of Poteligeo in the treatment of mycosis fungoides or Sézary syndrome

11 October 2021 - TLV has produced a health economic assessment for the regions for the drug Poteligeo (mogamulizumab).  ...

Read more →

Health economic assessment of Enhertu in breast cancer

11 October 2021 - TLV has produced a health economic assessment for the regions for the drug Enhertu.  ...

Read more →

TLV gets a leading role in European HTA project

29 September 2021 - TLV is one of 13 European authorities that are now part of a project called EUnetHTA21.  ...

Read more →

TLV is commissioned to secure access to antibiotics

13 September 2021 - TLV, the Swedish Public Health Agency and the Medical Products Agency have been commissioned by the Government ...

Read more →

Withdrawals from pharmaceutical benefits on 1 October 2021

8 September 2021 - Suboxone is among the medicines that will be withdrawn from the drug benefits at the companies' ...

Read more →

Health economic assessment of Sarclisa in multiple myeloma

6 September 2021 - TLV has produced a health economic assessment for the regions for the drug Sarclisa (isatuximab) in combination ...

Read more →

EndoPredict for breast cancer - the company chose not to participate with data

19 August 2021 - In November 2020, Myriad Genetics chose to refrain from participating in a health economic assessment of EndoPredict.  ...

Read more →

Withdrawals from the pharmaceutical benefits on 1 September 2021

10 August 2021 - Faslodex is among the medicines being withdrawn from the drug benefits on 1 September 2021. ...

Read more →

Health economic assessment of Oncotype DX in breast cancer

12 July 2021 - At the request of the regions' medical technology product council, the MTP council, TLV has carried out ...

Read more →

2021's first forecast of savings from side agreements

28 June 2021 - In a new report to the government, TLV forecasts that the pharmaceutical companies will pay approximately ...

Read more →

Update of handbook for companies applying for a subsidy

18 June 2021 - The Swedish Dental and Pharmaceutical Benefits Agency, TLV, has updated parts of the handbook for companies ...

Read more →

TLV receives a new assignment for precision medicine and advanced therapy drugs

15 June 2021 - The Swedish Dental and Pharmaceutical Benefits Agency, TLV, is commissioned by the government to continue the ...

Read more →

Sweden's cost of medicines is increasing

15 June 2021 - Sweden's costs for pharmaceuticals have risen by approximately SEK 2 billion between 2019 and 2020.  ...

Read more →